What Factors Propelled The Growth Of The Glycomics or Glycobiology Market In The Past?
The glycomics or glycobiology market has seen considerable growth due to a variety of factors.
• In recent years, the glycomics or glycobiology market has experienced quick growth. The market is anticipated to expand from $1.85 billion in 2024 to $2.13 billion in 2025, recording a compound annual growth rate (CAGR) of 15.2%. The previous growth can be credited to the heightened awareness of the role of glycans in biological systems, the broader resources and databases related to glycans, the increase in collaborative research efforts, progress in the synthesis and engineering of glycans, and the identification of glycan biomarkers.
How Will the Glycomics or Glycobiology Market?
The Glycomics or Glycobiology market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the glycomics or glycobiology market is projected to experience significant expansion, reaching a value of $4.03 billion by 2029, with a compound annual growth rate (CAGR) of 17.2%.
This growth during the predicted period can be credited to the integration of glycan-focused artificial intelligence (AI) and data analytics, the proliferation of drug development rooted in glycobiology, the role of glycomics in the detection of disease markers, customized medicine, and therapeutics based on glycans. Future trends within this period encompass interdisciplinary collaborations, the role of glycosylation patterns in the understanding of disease processes, innovative advancements in precision medicine and personalized treatment approaches, advancements in the instruments used for glycoanalysis, and the prominence of glycans in immunotherapy and vaccines.
Which Factors Are Boosting Growth In The Glycomics or Glycobiology Market?
The surge in the need for medications to treat numerous acute chronic diseases is projected to fuel the glycomics or glycobiology market's growth. Chronic ailments are typically long-lasting health issues that can be managed, but not cured. Glycomics research focuses on alterations in glycosylation and its functions, contributing to the creation of drugs and related treatments for a range of serious chronic conditions. For example, the American Cancer Society's scientific document, Cancer Facts and Figures 2022–2024, estimates that by 2032, there will be 22.5 million survivors of cancer (a chronic disease), which is anticipated to rise to 26 million survivors by 2040. Consequently, the increased need for pharmaceutical treatment for numerous acute chronic diseases is driving the growth of the glycomics or glycobiology market.
What Key Areas Define The Segmentation Of The Global Glycomics or Glycobiology Market?
The glycomics or glycobiology market covered in this report is segmented –
1) By Product: Enzymes, Kits, Reagents And Chemicals, Instruments, Carbohydrates
2) By Application: Drug Discovery And Development, Disease Diagnostics, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories
Subsegments:
1) By Enzymes: Glycosidases, Glycosyltransferases, Sialidases
2) By Kits: Glycan Analysis Kits, Glycobiology Research Kits
3) By Reagents And Chemicals: Monosaccharides, Oligosaccharides, Chemical Modifiers
4) By Instruments: Mass Spectrometers, Chromatography Systems, Imaging Systems
5) By Carbohydrates: Natural Carbohydrates, Synthetic Carbohydrates
Pre-Book The Glycomics or Glycobiology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Glycomics or Glycobiology Market?
A significant trend currently gaining traction in the glycomics or glycobiology field is the investment in research and development activities. Prominent research and development organizations are funding glycobiology research facilities, with the goal of advancing research in the glycomics or glycobiology sector. For instance, the Institute for Glycomics at Griffith University, located in Australia, launched the ACRF International Centre for Cancer Glycomics in August 2022. Bolstered by a $2.6 million ACRF grant, this unique facility aims to explore cancer glycocoding. The goal is to better understand the glycocode, in turn translating new findings into clinical outcomes that can enhance the lives of cancer patients.
Who Are the Key Players In The Glycomics or Glycobiology Market?
Major companies operating in the glycomics or glycobiology market include:
• Aligent Technologies Inc.
• Bruker Corporation
• Merck Co. & KgaA
• New England Biolabs Inc.
• Danaher Corporation
• Shimadzu Corporation
• ProZyme Inc.
• Takara Bio Inc.
• Asparia Glycomics SL
• Lectenz Bio
• Chemily Glycoscience LLC
• Z Biotech LLC
• RayBiotech Inc.
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Bio-Techne Corp.
• AMS Bio LLC
• Ludger Ltd.
• CD BioGlyco Ltd.
• GlycoDiag SAS
• Kode Biotech Limited
• Glyxera GmBH
• Glycomix Ltd.
• R&D Systems Inc.
What Is The Most Dominant Region In The Glycomics or Glycobiology Market?
North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
